Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
The drugmaker will soon give Twirla a twirl.
Agile's shares are heating up ahead of the company's Q1 earnings report.
No podcast episodes available.
AGRX earnings call for the period ending June 30, 2022.
AGRX earnings call for the period ending March 31, 2022.
AGRX earnings call for the period ending December 31, 2021.
AGRX earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.